Skip to main content
Journal cover image

Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis

Publication ,  Journal Article
Brot, P; Tan, P; Alifano, M; Camilleri-Brot, S; Richardson, S
Published in: BMC Medical Genomics
2009

Background. Genomic copy number alteration (CNA) that are recurrent across multiple samples often harbor critical genes that can drive either the initiation or the progression of cancer disease. Up to now, most researchers investigating recurrent CNAs consider separately the marginal frequencies for copy gain or loss and select the areas of interest based on arbitrary cut-off thresholds of these frequencies. In practice, these analyses ignore the interdependencies between the propensity of being deleted or amplified for a clone. In this context, a joint analysis of the copy number changes across tumor samples may bring new insights about patterns of recurrent CNAs. Methods. We propose to identify patterns of recurrent CNAs across tumor samples from high-resolution comparative genomic hybridization microarrays. Clustering is achieved by modeling the copy number state (loss, no-change, gain) as a multinomial distribution with probabilities parameterized through a latent class model leading to nine patterns of recurrent CNAs. This model gives us a powerful tool to identify clones with contrasting propensity of being deleted or amplified across tumor samples. We applied this model to a homogeneous series of 65 lung adenocarcinomas. Results. Our latent class model analysis identified interesting patterns of chromosomal aberrations. Our results showed that about thirty percent of the genomic clones were classified either as "exclusively" deleted or amplified recurrent CNAs and could be considered as non random chromosomal events. Most of the known oncogenes or tumor suppressor genes associated with lung adenocarcinoma were located within these areas. We also describe genomic areas of potential interest and show that an increase of the frequency of amplification in these particular areas is significantly associated with poorer survival. Conclusion. Analyzing jointly deletions and amplifications through our latent class model analysis allows highlighting specific genomic areas with exclusively amplified or deleted recurrent CNAs which are good candidate for harboring oncogenes or tumor suppressor genes. © 2009 Brot et al; licensee BioMed Central Ltd.

Duke Scholars

Published In

BMC Medical Genomics

DOI

ISSN

1755-8794

Publication Date

2009

Volume

2

Related Subject Headings

  • Genetics & Heredity
  • 1112 Oncology and Carcinogenesis
  • 1101 Medical Biochemistry and Metabolomics
  • 0604 Genetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brot, P., Tan, P., Alifano, M., Camilleri-Brot, S., & Richardson, S. (2009). Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis. BMC Medical Genomics, 2. https://doi.org/10.1186/1755-8794-2-43
Brot, P., P. Tan, M. Alifano, S. Camilleri-Brot, and S. Richardson. “Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis.” BMC Medical Genomics 2 (2009). https://doi.org/10.1186/1755-8794-2-43.
Brot P, Tan P, Alifano M, Camilleri-Brot S, Richardson S. Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis. BMC Medical Genomics. 2009;2.
Brot, P., et al. “Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis.” BMC Medical Genomics, vol. 2, 2009. Scival, doi:10.1186/1755-8794-2-43.
Brot P, Tan P, Alifano M, Camilleri-Brot S, Richardson S. Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis. BMC Medical Genomics. 2009;2.
Journal cover image

Published In

BMC Medical Genomics

DOI

ISSN

1755-8794

Publication Date

2009

Volume

2

Related Subject Headings

  • Genetics & Heredity
  • 1112 Oncology and Carcinogenesis
  • 1101 Medical Biochemistry and Metabolomics
  • 0604 Genetics